Folic acid and vitamin B12 are involved in chemical reactions which lead to the formation of nucleic acids in living cells. These relationships are amply demonstrated by studies in bacterial (1) (2) (3) (4) (5) , animal (6) , and human (7) metabolism. It appears likely that folic acid is essential to the formation of various purines and pyrimidines such as thymine from endogenous sources of carbon and amino nitrogen as well as to the interconversion of these substances or of their ribosides (8) . Vitamin B12, on the other hand, appears to be active in the formation of ribosides, such as thymidine, from these purines and pyrimidines. Folic acid and vitamin B12, therefore, appear to be active at different stages of a chemical chain reaction which leads to the formation of nucleic acids.
In this paper, we wish to report a method of direct instillation of test substances into human bone marrow cavities. By such a method, observations may be made on the effect of various substances to be tested on marrow cells in their natural environment. By the use of this method, evidence has been obtained that vitamin B,2 can be utilized unchanged by the megaloblasts and early erythroblasts of patients with pernicious anemia in relapse. On the other hand, folic acid has no such direct effect. Methyl green-pyronin stain applied to the erythroblasts of patients with pernicious anemia in relapse before and after the instillation of vitamin B12 into the bone marrow indicates that vitamin B12 corrects a qualitative abnormality of the cytoplasmic ribonucleic acid of these cells. Folic acid has a similar effect only after oral or parenteral administration and is presumably acti-vated by enzymatic activity elsewhere in the body. These data offer additional evidence relating vitamin B12 and folic acid to nucleic acid metabolism.
MATERIAL AND METHODS
Injections into the marrow cavities of the iliac crests of six persons with pernicious anemia in relapse were performed as follows: three received 1 microgram of crystalline vitamin B123 and three received 1 or 2 mugs. of folic acid. 4 In each instance, the material was injected slowly in 1 c.c. of solution after aspiration of 2-3 c.c. of marrow and blood. Moderate pain accompanied the injection and was diminished by slowing the rate of instillation. Forty-eight hours later, bone marrow was again aspirated from the exact site of previous instillation and also from the opposite iliac crest. The site of instillation was easily located by using the trauma produced by the earlier puncture as a landmark. In one case, marrow was aspirated also from sites 4 and 8 centimeters distant from the site of instillation of the vitamin B12. Coverslip preparations were made of each marrow specimen obtained and stained 1) with WrightGiemsa stain for differential cell counts, 2) with methyl green and pyronin B (9) for demonstration of cytoplasmic ribonucleic acid, and 3) by a Stowell's modification of the Feulgen method (10) for demonstration of desoxyribonucleic acid. The methyl green-pyronin stain was prepared by mixing three parts of a 1 per cent solution of methyl green 5 containing 0.25 per cent liquefied phenol S The material used was "Cobione," supplied by Merck and Co., Inc., Rahway, N.J., and provided in 1 c.c. ampules containing 10 micrograms of crystalline vitamine B,2 per cc. Appropriate dilutions were made for this study with physiologic saline solution. 4 The material used was "Folvite," supplied as a powder by the Lederle division of the American Cyanamid Corp., Pearl River, N.Y. Solutions containing 1 or 2 mgs. of folic acid per c.c. were made in distilled water containing sodium bicarbonate sufficient for a pH of approximately 7.5. 5 Methyl green and pyronin B were obtained from the National Aniline Division, Allied Chemical and Dye Corp., New York, N.Y. The stains used were certified by the Biological Stain Commission. ribonucleic acid in the cytoplasm of.youn-g erythroid cells were observed in methyl green-pyronin stained preparations of bone marrow from a patient with erythroid hyperplasia resulting from anemia of chronic blood loss. Study of such a preparation ( Figure 3 ) reveals a diffuse and homogeneous distribution of the red granules throughout the cytoplasm of the early erythroblasts. In the later forms, they seem to become more condensed and clumped. Finally, during the normoblastic stage of the development of the erythrocyte, the red color, indicating cytoplasmic ribonucleic acid, disappears altogether. Methyl green-pyronin stained marrow preparations from patients with pernicious anemia in relapse, one of which is presented in Figure 4 -A, show that the distribution of the cytoplasmic ribonucleic acid is quite different in this disease. In these preparations, there is condensation and (Figure 4-B (X 650) becomes more diffuse and homogeneous; and, in general, it assumes the characteristics of that observed in early erythroblasts from a patient with anemia due to chronic blood loss.
No change in the clumped cytoplasmic ribonucleic acid was noted 48 hours after the local marrow instillation of folic acid. However, when folic acid was given orally or intramuscularly in therapeutic doses, the cytoplasmic ribonucleic acid became homogeneous and of more normal appearance.
The appearance of desoxyribonucleic acid stained by Stowell's modification of the Feulgen method was not altered in the preparations obtained after the instillation either of vitamin B12 or of folic acid. Furthermore, the desoxyribonucleic acid in erythroblasts from persons with pernicious anemia in relapse had the same appearance as that from a person with anemia of chronic blood loss.
DISCUSSION
The normal maturation of erythroblasts in the bone marrow of persons with pernicious anemia in relapse observed at the site of instillation of vitamin B12 but not in marrow from the opposite ilium demonstrates that vitamin B12 can be utilized directly by bone marrow cells without alteration by any other organ or tissue. Therefore, if vitamin B12 and extrinsic factor of food are the same substance, as seems probable, this experiment provides direct evidence that extrinsic factor need not be chemically changed by intrinsic factor or by the liver before becoming active for erythrocyte maturation. This, of course, is not a new concept. Studies of Berk and his associates (12) on hematologic responses in persons with pernicious anemia, who received vitamin B12 and refined liver extract orally along with normal human gastric juice, suggest that vitamin B12 (presumably extrinsic factor of food) and the antipernicious anemia principle of liver are identical or closely related compounds. After observing the magnitude of fecal elimination of vitamin B12 in patients with untreated pernicious anemia and the hematologic responses in similar patients obtained by the administration of 10 per cent alcoholic extracts of beef muscle, they concluded that . . the function of the intrinsic factor of normal human gastric juice is to facilitate the absorption 34 AF M.rcE by the intestine of vitamin B12 . . . rather than to react with the extrinsic factor as hitherto assumed." On the other hand, in our experiment, folic acid was not utilized unchanged within 48 hours after instillation of the substance into the marrow cavity. Observations by others provide further data that folic acid, acting as a substrate, in some way must be altered before becoming active in hematopoiesis. Norris and Majnarich have reported that folic acid has no effect on hematopoiesis as observed by an in zitro rabbit bone marrow culture technique (13) . However, after this substance was incubated with milk xanthine oxidase, liver homogenate, or extract of rat gastric mucosa, it became hematopoietically active as demonstrated by this method (14) . Tove and Elvejhem (15) have reported the presence of a substance in methanol extract of liver which has a sparing effect on folic acid in the metabolism of mink. Furthermore, this substance protected these animals from folic acid deficiency produced by feeding them 7-methyl folic acid.
Further stimulation to the study of the mode of action of folic acid in hematopoiesis was provided by the concentration by Sauberlich (16) of a substance in rat urine which is a growth factor for Leuconostoc citrovorum 8081. Studies on this factor, termed the "citrovorum factor," have demonstrated that 1) the urinary excretion of the substance is increased by oral administration of folic acid both in rats (17) and in human beings (17, 18) , and 2) the substance counteracts the toxicity of aminopterin as measured by growth of L. citrovorum (17) . Data are not yet available on the hematopoietic activity of this substance in erythrocyte maturation factor deficiency anemia. Preliminary studies in this laboratory indicate that the local marrow instillation of four million units of "citrovorum factor" does not result in stimulation of erythrocyte maturation in persons with pernicious anemia in relapse.
The changes observed in the cytoplasmic ribonucleic acid of erythroid precursor cells in marrow from subjects with pernicious anemia in relapse as compared with those from persons with anemia of chronic blood loss provide data linking erythrocyte maturation factor deficiency anemia to abnormalities in nucleoprotein metabolism. Thorell, in 1947 (19) , correlated, by cytochemical and ultraviolet microphotographic studies, endocellular growth process in hematopoiesis with the presence of ribonucleic acid in the granulocytic and erythroid precursor cells in bone marrow. Briefly, he found that growth and new cellular protein formation during hematopoiesis are associated with high concentrations of ribonucleic acid in the cytoplasm and the nucleolus of these cells; as growth activity declines, the concentrations of ribonucleic acid decrease proportionately. In normal erythropoiesis, hemoglobin synthesis does not begin until the ribonucleic acid metabolism is completed; after this, the synthesis of hemoglobin proceeds rapidly. In pernicious anemia, there is an abnormality in these relationships of growth and differentiation; in this disease, hemoglobin synthesis begins while the ribose polynucleotide content of the cell is still high. The apparent correction of this abnormality observed in our study after the local marrow instillation of vitamin B12 provides additional data linking vitamin B12 and nucleoprotein metabolism. 
